evekhm/cms_iom_500 huggingface dataset:
(Medicare National Coverage Determinations Manual)
10/16/2009  Magnetic Resonance Imaging (MRI)  01/04/2010  6672  R106NCD  09/18/2009  FDG PET for Solid Tumors and Myeloma - Rescinded and replaced by Transmittal 108  10/19/2009  6632  R105NCD  08/07/2009  Screening Computed Tomography Colonography (CTC) for Colorectal Cancer  09/08/2009  6578  R104NCD  07/17/2009  FDG PET for Solid Tumors and Myeloma and Additional Manual Updates  Rescinded and replaced by CR 6632, Transmittal 106  08/17/2009 and 10/05/2009 6464  R103NCD  07/10/2009  Sleep Testing for Obstructive Sleep Apnea (OSA)  08/10/2009  6534  R99NCD  02/13/2009  Heartsbreath Test for Heart Transplant Rejection  04/06/2009  6366  R96NCD  10/15/2008  Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)  08/04/2008  6048  R95NCD  09/10/2008  Artificial Hearts  12/01/2008  6185  R94NCD  08/29/2008  Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) -  Rescinded and replaced by Transmittal 96  08/04/2008  6048  R93NCD  08/29/2008  Artificial Hearts - Replaced by Transmittal 95  10/06/2008  6185  R92NCD  08/08/2008  Screening DNA Stool Test for Colorectal Cancer  08/25/2008  6145  R91NCD  07/25/2008  Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) -  Rescinded and replaced by Transmittal 94  08/04/2008  6048  R89NCD  07/25/2008  Screening DNA Stool Test for Colorectal Cancer -  Rescinded and replaced by Transmittal 92  08/25/2008  6145  R86NCD  07/03/2008  Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) -  Rescinded and replaced by Transmittal 91  08/04/2008  6048  R85NCD  06/27/2008  Cardiac Computed
(Medicare National Coverage Determinations Manual)
Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) -  Rescinded and replaced by Transmittal 91  08/04/2008  6048  R85NCD  06/27/2008  Cardiac Computed Tomographic Angiography (CTA)  07/28/2008  6098  R84NCD  06/27/2008  FDG PET for Infection and Inflammation  07/28/2008  6099  R83NCD  05/02/2008  Blood -Derived Products for Chronic, Non -Healing Wounds  06/02/2008  6043  R79NCD  12/21/2007  Nebulized Beta Adrenergic Agonist Therapy for Lung Disease  01/22/2008  5820  R78NCD  12/05/2007  Pulmonary Rehabilitation Services  01/07/2008  5834  R76NCD  09/12/2007  Ultrasound Diagnostic Procedures  09/28/2007  5608  R74NCD  09/07/2007  Medicare Clinical Trial Policy (CTP)  10/09/2007  5719  R73NCD  09/06/2007  Ultrasound Diagnostic Procedures - Replaced by Transmittal 76  09/28/2007  5608  R72NCD  08/28/2007  Ultrasound Diagnostic Procedures  09/28/2007  5608  R65NCD  02/23/2007  INDEPENDENCE iBOT 4000 Mobility System  04/02/2007  5372  R62NCD  12/15/2006  Infrared Therapy Devices  01/16/2007  5421  R59NCD  06/09/2006  Non-Autologous Blood Derived Products for Chronic Non -Healing Wounds  07/10/2006  5123  R58NCD  05/26/2006  Intestinal and Multi -Visceral Transplantation  06/26/2006  5090  R57NCD  05/26/2006  Home Use of Oxygen in Approved Clinical Trials  10/03/2006  4389  R56NCD  05/19/2006  Pancreas Transplants Alone  07/03/2006  5093  R55NCD  05/05/2006  Changes Conforming to CR 3648 Instructions for Therapy Services  10/02/2006  4014  R51NCD  04/07/2006  Nesiritide for Treatment of Heart Failure Patients  05/22/2006  4312  R48NCD  03/17/2006  Technical Corrections to the NCD Manual  06/19/2006  4278  R44NCD  12/02/2005  Lung Volume Reduction Surgery
(Medicare National Coverage Determinations Manual)
for Treatment of Heart Failure Patients  05/22/2006  4312  R48NCD  03/17/2006  Technical Corrections to the NCD Manual  06/19/2006  4278  R44NCD  12/02/2005  Lung Volume Reduction Surgery  03/02/2006  4149  R37NCD  06/03/2005  Mobility Assistive Equipment (Mobility Assistive Equipment (MAE)  05/05/2005  3791  R36NCD  05/20/2005  Smoking and Tobacco -Use Cessation Counseling  07/05/2005  3834  R35NCD  05/06/2005  Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)  06/06/2005  3843  R31NCD  04/01/2005  PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers  04/18/2005  3741  R27NCD  02/04/2005  Infusion Pumps: C -Peptide Levels as A Criterion for Use  02/18/2005  3705  R24NCD  10/01/2004  Update to Chapter 1, Section 220.6 - Dementia and Neurodegenerative Diseases  10/04/2004  3426  R21NCD  09/10/2004  Magnetic Resonance Spectroscopy for Diagnosing Brain Tumors  09/10/2004  3425  R19NCD  07/30/2004  Blood -Derived Products for Chronic Non -Healing Wounds  07/23/2004  3384  R18NCD  07/30/2004  Islet Cell Transplantation  10/04/2004  3385  R10NCD  04/06/2004  Re-release of NCD Manual  N/A N/A R07NCD  03/19/2004  Wound Treatment  07/06/2004  3149  R05NCD  12/19/2003  Colorectal Cancer Screening Tests  01/05/2004  2996  R03NCD  11/04/2003  Lung Volume Reduction surgery  01/05/2004  2688  R01NCD  10/01/2003  Initial Release of Manual  N/A N/A Back to top of Chapter
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
CMS National Coverage PolicyCMS National Coverage Policy:Language quoted from Centers for Medicare and Medicaid Services (CMS), National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals is italicized throughout the policy. NCDs and coverage provisions in interpretive manuals are not subject to the Local Coverage Determination (LCD) Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See Section 1869(f)(1)(A)(i) of the Social Security Act.Unless otherwise specified, italicized text represents quotation from one or more of the following CMS sources:Title XVIII of the Social Security Act(SSA):Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.Section 1862 (a)(7) excludes routine physical examinations, unless otherwise covered by statute.Article TextImplanted cardioverter-defibrillators require periodic evaluation of function and reprogramming based upon the patient's medical condition. Interrogation may be provided during a face-to-face encounter or remotely. The interrogation and evaluation may be provided as routine follow-up in an asymptomatic patient without device discharge, or for symptoms, with device discharge. Reprogramming should be reflected by a need for change in the patient's medical condition.Remote interrogation is a 90-day service, inclusive of all transmissions during that period which are then billed as a single service. A provider may not bill a remote service and a face-to-face service on the same day.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
Remote interrogation is a 90-day service, inclusive of all transmissions during that period which are then billed as a single service. A provider may not bill a remote service and a face-to-face service on the same day.Medicare will cover surveillance of ICDs as a face-to-face or remote service to monitor behavior of the device, to investigate symptoms such as post-event shock, and syncope, ICD malfunction or device failure. Surveillance of ICDs is also indicated to program device evaluation and adjustment and for patients prior to surgery or other procedures to modify or disable the device during the procedure. Remote interrogation is a single 90-day service, while in-person interrogation can be reported for each day it is performed.Peri-procedural device evaluation and programming before and/or after a procedure or test may be reported separately.Billing Information:Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.For services requiring a referring/ordering physician, the name and UPIN or NPI of the referring/ordering physician must be reported on the claim.The diagnosis code(s) must best describe the patient's condition for which the service was performed.A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.Advance Beneficiary Notice of Noncoverage (ABN) Modifier GuidelinesAn ABN may be used for services which are likely to be non-covered, whether for medical necessity or for other reasons. Refer to CMS Publication 100-04,Medicare Claims Processing Manual,Chapter 30, for complete instructions.Surveillance of an ICD is indicated to monitor the behavior of the device and to assess the patient with intervening symptoms. The frequency and need for both face-to-face and remote interrogation should be coordinated so that there is no unnecessary duplication of the interrogation services.The symptoms requiring unscheduled investigation by both remote and face-to-face modalities should be discrete symptoms such as post-shock events, syncope/near-syncope and palpitations. Remote and face-to-face interrogations may be performed for suspected malfunction or device failure.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
In-person evaluation/interrogation services (93287, 93289, and 93292) may be reported each time they are provided (reimbursement is dependent upon documentation of medical necessity).Remote interrogation services 93295 and 93296 are 90-day services, and may only be reported once during that period regardless of the number of interrogations performed. The 90-day period begins with the initiation of remote monitoring or the 91st day of the implantable defibrillator.In-person interrogation occurring during the same 90-day period as remote interrogation is included in the remote interrogation service. If there is no interrogation service provided within a 90-day period then the service should not be billed for that period. Programming services may be reported separately.In-person interrogation performed on the same day as the programming of the device is included in the programming service.Interrogation and reprogramming of defibrillators prior to and after a surgical procedure or test (93287) is covered as a separate procedure when it is necessary to modify how the device would function during the procedure/test (e.g., to avoid interference by an electrical cautery during the procedure, to disable during cardiac surgery, etc).When performing program device evaluation with iterative adjustment of the device to test function and select optimal programmed parameters, the final parameters may or may not change from previous parameters. Documentation of each parameter tested and the result should be maintained in the record.For physician billing, each interrogation, with/without reprogramming must be provided underdirectsupervision of the physician in a hospital or other facility setting and alsodirect supervision in the office or private clinic setting. The physician must personally review and analyze the data,generate a reportand sign it.For hospital billing, the technical component of these tests,each interrogation, with/without reprogramming must be provided under direct supervision of a qualified physician in the hospital. A qualified physician must personally review and analyze the data,generate a reportand sign it if a professional component (-26) isbilled. If performed in the hospital, a physician cannot bill for the technical component.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
When the technical portion of interrogation services are provided by a service center (IDTF, hospital based laboratory, etc), or physician other than the one analyzing and interpreting the results (93296), the physician performing the review, analysis and report must generate his/her own interpretation and report (with signature) and not just countersign the technical review and distribution of results.These evaluation/interrogation services should not be billed when implanting or replacing an ICD.The service must be prescribed by a physician or a qualified non-physician practitioner.An evaluation and management (E&M) service provided on the same day as in-person interrogation/programming must be a significant and separately identifiable face-to-face service. No part of the ICD surveillance (face-to-face or Internet based) may be reported as an E&M service. A brief history to ascertain whether the device has discharged or patient has had symptoms relevant to the need for the device (and therefore function) is considered part of the surveillance service. EKG rhythm strips (93040-93042) are included in these evaluation/interrogation services and should not be billed separately.Coverage is limited to system(s) approved by the FDA for patients with a specific implanted ICD model.Only physicians who have expertise and/or training in reprogramming of ICDs may bill the interrogation with or without reprogramming services.Utilization Guidelines:The frequency and need for both face-to-face and web-based modalities should be coordinated so that there are no unnecessary duplications of the interrogation services.When the in-person service is rendered for monitoring purposes only, in the absence of symptoms or discharge of the device (ICD-10-CM code Z95.810), it is expected that the service be performed no more frequently than once every three months. Remote interrogation services may be billed no more often than once every 90 calendar days.When the in-person service is rendered for other indications, it may be performed as appropriate based on clinical symptomatology.Documentation Requirements:The patient's medical record must contain documentation that fully supports the medical necessity for services included within this article. This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
An Internet based service may require a signed service agreement between the manufacturer and the physician. This agreement should be kept on file and be available upon request.When the technical portion of interrogation services are provided by a service center (IDTF, hospital based laboratory, etc), or physician other than the one analyzing and interpreting the results (93296), the physician performing the review, analysis and report must generate his/her own interpretation and report (with signature) and not just countersign the technical review and distribution of results.All of the following must be maintained in the patients medical record in the physicians office: date(s) of device implant and identification of device, a copy of the physicians order for the service, all transmissions, formal interpretations, reports, information relating the reason for the service: routine follow-up versus specific symptoms. If the reason for the service is that the patient was symptomatic, then the nature of the symptoms must be documented.Evaluation/Interrogation Billing:In-person evaluations/interrogation services (93287, 93289, and 93292) may be reported each time the services are provided (reimbursement is dependent upon documentation of medical necessity). These services should not be billed when implanting or replacing an ICD.Remote interrogation services 93295 and 93296 are 90-day services, and may only be reported once during that period regardless of the number of interrogations performed. The 90-day period begins with the initiation of remote monitoring or the 91st day of the implantable defibrillator.In-person interrogation occurring during the same 90-day period as remote interrogation is included in the remote interrogation service and should not be separately billed for that period. If there is no interrogation service provided within a 90-day period then the service should not be billed for that period. Programming services may be reported separately.In-person interrogation performed on the same day as the programming of the device is included in the programming service and should not be separately billed.Remote services should be reported with the place of service where the physician or service center is located, and not the location of the patient.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
Remote services should be reported with the place of service where the physician or service center is located, and not the location of the patient.CPT code 93287 should be billed for interrogation and reprogramming of defibrillators prior to and after a surgical procedure or test if it is necessary to modify how the device would function during the procedure/test (e.g., to avoid interference by an electrical cautery during the procedure, to disable during cardiac surgery, etc). Therefore, this service may be reported once before a surgery or other procedure and once after surgery or other procedure if performed at both times.The technical portion of interrogation services, when provided by a service center (IDTF, hospital based laboratory, etc), or physician other than the one analyzing and interpreting the results should be billed with CPT code 93296.Providers should only report an evaluation and management (E&M) service on the same day as in-person interrogation/programming, if it is a significant and separately identifiable face to face service. In these cases, modifier 25 should be billed with the E&M service.A brief history to ascertain whether the device has discharged or patient has had symptoms relevant to the need for the device (and therefore function) is considered part of the surveillance service.EKG rhythm strips (93040-93042) are included in these evaluation/interrogation services and should not be billed separately.ICD-10-CM Coding:Report ICD-10-CM code Z45.02 for interrogation and reprogramming of defibrillator prior to undergoing a surgical procedure unrelated to defibrillator.Report ICD-10-CM code Z48.89 for interrogation and/or reprogramming of defibrillator following a surgical procedure unrelated to defibrillator.For claims submitted to the Part B MAC:All services/procedures performed on the same day for the same beneficiary by the physician/provider should be billed on the same claim.Sources of Information:This bibliography presents those sources that were obtained during the development of this article. National Government Services is not responsible for the continuing viability of Web site addresses listed below.American Medical Association,CPT 2009 Professional Edition,pages 408-411.Medtronic CareLink Network, Fact Sheet, Press Release, Backgrounder by Medtronic, Inc.
Article - Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based (A53018)
American Medical Association,CPT 2009 Professional Edition,pages 408-411.Medtronic CareLink Network, Fact Sheet, Press Release, Backgrounder by Medtronic, Inc.Medtronic completes Phase One of its Medtronic CareLink Patient Management Network Rollout, Company Press Release, Atlanta-March 18, 2002 @ http://www.cathlab.com.ar/revista/industrial/industria.htm FDA approves Web-based heart monitoring system by Alicia Ault, New York, Jan 03 (2002), Reuters Health Information @http://www.reutershealth.com/archive/2002/01/03/e/20020103elin021.htm.New Smart Pacemakers, ICDs Will Even Contact Your Doctor For You, News and Press Releases, San Diego Tuesday, May 07, 2002, North American Society of Pacing and Electrophysiology (NASPE) @http://www.naspe.org/.
Article - Polysomnography and Sleep Studies – Medical Policy Article (A53019)
CMS National Coverage PolicyN/AArticle TextAbstract:Sleep studies and polysomnography refer to the continuous and simultaneous monitoring and recording of various physiological and pathophysiological parameters of sleep with 6 or more hours of recording with physician review, interpretation and report. The studies are performed to diagnose a variety of sleep disorders and to evaluate a patient's response to therapies such as continuous positive airway pressure (CPAP). Polysomnography is distinguished from sleep studies by the inclusion of sleep staging.The CMS National Coverage Determination (NCD) Sleep Testing for Obstructive Sleep Apnea (OSA) describes nationally covered indications for sleep testing, the details of which will not be repeated here. This Medical policy article describes sleep study credentialing and documentation requirements.Indications and Limitations:For all hospital based facilities, the facility must beunder the direction and control of physicians that are board certified or eligible in sleep medicine. All non-hospital based facilities must be certified by theAmerican Academy of Sleep Medicine, The Joint Commission, or theAccreditation Commission for Health Care, Inc.Medicare does not cover sleep studies performed in mobile sleep laboratories.The sleep laboratory or testing facility must be affiliated with a hospital or be under the direction and control of a physician (MD/DO), even though the diagnostic test may be performed in the absence of direct physician supervision. The laboratory physician director must be/have:Board-certified in sleep medicine (ABSM, i.e., Diplomate of, or board-eligible for, the American Board of Sleep Medicine; orA diplomate or board-eligible for an American Board of Medical Specialties (ABMS) approved board; orCompleted residency or fellowship training by an ABMS member board and has completed all the requirements for subspecialty certification in sleep medicine except the examination itself, and only until the time of reporting of the first examination for which the physician is eligible; orAn active staff member of a sleep center or laboratory accredited by the American Academy of Sleep Medicine (AASM), the Accreditation Commission for Health Care, Inc. or The Joint Commission (formerly the Joint Commission on Accreditation of Healthcare Organizations (JCAHO); orCompleted training and certification from the National Board for Respiratory Care (NBRC) Inc.